Articles On Webster (ASX:WBA)

The ASX is set to open lower on Wednesday, tracking Wall Street The debt ceiling impasse is likely to be resolved by “end of the week” Sam Altman’s other investments outside of ChatGPT   Local shares will open lower this morning after a s...

At the start of each week, I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high lev...

Are you wanting to gain some exposure to the tech sector? If you are, then you might want to consider the two tech shares named below that Goldman Sachs is recommending as buys. Especially with the broker tipping major upside potential ahe...

The rise of Amazon.com Inc (NASDAQ: AMZN) here in Australia has been spooking ASX retail shares and their investors for more than five years now. Ever since Amazon first launched its local marketplace here in Australia back in 2017, invest...

At the start of each week, I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high lev...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think th...

There are a lot of growth shares for investors to choose from on the ASX. To narrow things down, I have picked out three ASX growth shares that have recently been tipped as buys with major upside potential. Here’s what you need to know:...

Dimerix is looking to raise $12 million to continue its phase 3 Focal Segmental Glomerulosclerosis (FSGS) clinical trial past first interim data. Clinical stage biopharmaceutical company Dimerix (ASX:DXB) has announced a $12 million capita...

ASX growth shares have taken a beating over the last year and a half. But I think there are opportunities to pounce on before a possible recovery. Just because something has gone down doesn’t automatically mean it’s going to rise again...

At the start of each week, I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high lev...

The ASX share market has been through loads of volatility over the last couple of years. But, this could be a great time to invest in ASX growth shares in my opinion. We want to be able to buy good businesses at the lowest possible price....

Stockhead’s resident health and biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.  In this episode Tim chats to Nina Webster, CEO & managing direct...

Growth investors certainly are spoilt for choice on the Australian share market. But which ASX growth shares should you buy over others? Three that are highly rated right now are named below. Here’s why analysts are tipping them as buys:...

Jarden’s preferred exposures to online retail, online penetration trends & the improving outlook for diagnostic imaging in Australia. -The trend for online retail penetration in Australia-A favourable outlook for Australian diagnostic i...

Goldman Sachs has just hosted 19 companies and 200 investors at its 14th Annual Emerging Leaders Conference. Three ASX small and mid-cap shares that were at the event and impressed Goldman are listed below. Here’s why the broker rates th...

If you’re like me and have a penchant for ASX growth shares, then it could be worth checking out the two listed below. Analysts at Goldman Sachs are very bullish on these shares and are tipping some strong gains over the next 12 months....

Analysts at Liberum Capital have listed ASX lithium stock Atlantic Lithium Ltd (ASX: A11) among the resources shares they are positive about for the future. The Atlantic Lithium share price has dropped nearly 13% in the year to date. In...

Some ASX growth shares have taken a proper beating over the last couple of years. Rising interest rates, the increased cost of debt, and macroeconomic uncertainty have culminated in reduced investor appetite for risk. This has sent the ma...

The ASX share market has gone through some seismic shifts over the last three years. I think this is a great time to be looking at fallen ASX growth shares as recovery buys. It’s understandable why some e-commerce players have fallen su...

The Temple & Webster Group Ltd (ASX: TPW) share price is heading in the right direction again on Thursday. In morning trade, the ASX 300 stock is up 1.5% to $3.49. Though, this is little consolation for longer term shareholders that ha...

The current environment presents near-term challenges for online retail stocks But those with strong unit economics could survive and thrive Stockhead reached out to Redbubble co-founder and newly appointed CEO, Martin Hosking   Inflation...

Are you wanting to buy some ASX growth shares but aren’t sure which ones to buy? Don’t worry, because analysts have recently tipped the two listed below as buys. Here’s why these could be the growth shares to buy right now: Aristocr...

Investors looking for ASX growth shares to buy might want to check out the two listed below. These shares have been named as buys and tipped to climb meaningfully higher from current levels. Here’s what you need to know: Pilbara Minerals...

Several ASX health stocks are seeking US FDA approval for drugs/devices in the near future Telix Pharmaceuticals is chasing renal cancer imaging approval for TLX-250 CDx Aroa is awaiting an FDA decision on the required regulatory pathway...

The ASX share market is presenting lots of opportunities to invest in during this volatile period. I think there are some great opportunities to pursue with $10,000. It’s not often that we get to invest at times of great market distress,...

What a terrific weekend of crisis it’s been both at the summit of Swiss political power and in the dark and secret situation rooms of the twin Swiss banking giants – Switzerland’s children – UBS and Credit Suisse. There was movement at the...

Online retailer Kogan.com, along with six other ASX-listed companies, have been dropped from the S&P/ASX All Technology Index, as part of a quarterly rebalancing of indices. The change takes effect from today, March 20. Alongside Kogan....

The investment team at Wilson Asset Management (WAM) has picked out some ASX shares that could be undervalued and prime buying opportunities. WAM runs a number of different listed investment companies (LICs) including WAM Research Limited...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think th...

While the recent market volatility has been disappointing, this pullback is nothing compared to what some ASX growth stocks have experience over the last 12 months. For example, the three growth stocks listed below are down between 40% and...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is off its lows but still on course to record a disappointing decline. The benchmark index is currently down 1.45% to 6,966.3 points. Four ASX shares that are not letting that hold...

The S&P/ASX 200 Index (ASX: XJO) is tumbling today, but most S&P/ASX All Ordinaries Index (ASX: XAO) gold shares are defying the sell-off to leap higher. Gold shares shining brightly today include: Newcrest Mining Ltd (ASX: NC...

The Temple & Webster Group Ltd (ASX: TPW) share price is under the spotlight this morning after announcing a $30 million share buyback. As a reminder, Temple & Webster is an online retailer of furniture and homewares. It sells over...

The Temple & Webster Group Ltd (ASX: TPW) share price is defying the market weakness and pushing higher on Thursday. In morning trade, the online furniture retailer’s shares are up 1.5% to $3.52. However, despite this, the Temple &am...

I love taking advantage of lower priced ASX shares when they’re there as opportunities. I’m going to write about two I like the look of. Beaten-up prices are only there for so long if the business is going to go through a recovery. The mark...

Most people are familiar with the deluge of artificial intelligence (AI) apps that seem designed to make us more efficient and creative. We’ve got apps that take text prompts and generate art, and the controversial ChatGPT, which raises ser...

Are you wanting to make some new additions to your portfolio? If you are, then analysts think the two ASX 200 shares listed below could be worth considering. Here’s why these shares are rated as buys: Altium Limited (ASX: ALU) The firs...

Looking for a growth share or maybe two to buy? If you are, you may want to look at the two listed below. Here’s why these ASX growth shares are rated highly right now: Temple & Webster Group Ltd (ASX: TPW) The first ASX growth shar...

Latest ASX earnings season shows unevenness in opportunities and obstacles to performance going forward Labour shortages, inflation and increasing costs of capital visible takeaways from company reports Datt Capital expect insurance and no...

Are you wanting to add a growth share or two to your portfolio? If you are, then analysts at Goldman Sachs think the two listed below could be worth considering. Here’s why these growth shares are rated as buys: Aristocrat Leisure Limite...

The ASX share market has significant investing opportunities to consider, with some of them potential market-beaters at today’s prices. I don’t think that day trading is an effective investment strategy. But I think it’s possible to...

Are you interested in adding some ASX growth shares to your portfolio? If you are, you may want to look at the share listed below that Goldman Sachs has on its conviction list. Here’s what you need to know about this buy-rated growth sha...

Dimerix has welcomed news late last week that the US Food and Drug Administration (FDA) has approved the drug Sparsentan for Immunoglobulin A nephropathy (IgAN) another type of rare (orphan) kidney disease. The company says this approval is...

There are some All Ordinaries (ASX: XAO), or All Ords, ASX shares that have fallen heavily over the past year or so. I think that some of these beaten-up names could be some of the best opportunities to buy for a two-year or three-year tim...

ShareCafeThe Week that Was: February 13-17, 2023 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so...

World Overnight SPI Overnight 7315.00 + 36.00 0.49% S&P ASX 200 7352.20 – 78.70 – 1.06% S&P500 4147.60 + 11.47 0.28% Nasdaq Comp 12070.59 + 110.45 0.92% DJIA 34128.05 + 38.78 0.11% S&P500 VIX 18.23 – 0.68 – 3.60%...

The S&P/ASX 200 Index (ASX: XJO) share market is facing an uncertain time for the rest of 2023. While the market fell in 2022, it essentially recovered all of that lost ground in January 2023 after gaining 6%. But, since early February...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ANN)) - Ansell ((BRG)) - Breville Group ((CGF)) - Challenger ((CSL)) - CSL ((DXS)) - Dexus ((JHX)) - James Hardie Industries ((RKN)) - Reckon ((SWM)) - Seven West Media...

In this video Scott speaks with Gary Rollo, portfolio manager of the Montgomery Small Companies Fund to provide an early update on what we have seen from reporting season so far. It is early, but we can already see some key messages coming...

It’s probably fair to say that this week has been one of, if not the, worst week in the history of the Star Entertainment Group Ltd (ASX: SGR) share price. Star, an ASX 200 gaming and casino share, fell off a cliff on Monday when the compa...